@FierceBiotech: Buzz: GlaxoSmithKline prepares to unveil a new PhIII lineup. Story | Follow @FierceBiotech
@JohnCFierce: Eager biotechs (9!) crowd into Wall Street this week with $500M in IPO pitches. News | Follow @JohnCFierce
@DamianFierce: Portola takes its 'breakthrough' bleeding drug to PhIII with Bayer, J&J in tow. Read | Follow @DamianFierce
@EmilyMFierce: Merck halts drug testing on chimpanzees. Story | Follow @EmilyMFierce
> Agios Pharmaceuticals ($AGIO) says it is hanging on to the U.S. commercialization rights to AG-120 and its isocitrate dehydrogenase 1 (IDH1) portfolio, part of a big pact the biotech struck with Celgene ($CELG). Celgene will take the development lead outside the U.S. Release
> Regado Biosciences ($RGDO) is raising $20 million in a private placement. Release
@FierceMedDev: Montagu Private Equity grabs Rexam's healthcare packaging arm for $805M. Story | Follow @FierceMedDev
@MarkHFierce: ArthroCare, stained by a federal fraud scandal, gets a fresh start with Smith & Nephew's planned $1.7B acquisition. More | Follow @MarkHFierce
@MichaelGFierce: Study reports success in targeted therapy for common form of lung cancer. Report | Follow @MichaelGFierce
@EmilyWFierce: Given Imaging scores FDA seal of approval for PillCam COLON device. News | Follow @EmilyWFierce
> Neovasc makes a first-in-human implant of its transcatheter mitral valve. More
> Apple joins Google on FDA med tech regulators' meeting calendar. Story
Pharma News
@FiercePharma: WSJ: Scientist's lawsuit accuses AstraZeneca of fudging Brilinta study. Story | Follow @FiercePharma
@TracyStaton: Biogen Idec's Tecfidera nabs EU approval for first-line MS treatment. Rollout TK. More | Follow @TracyStaton
@EricPFierce: The FDA says it will take a look at the heart risks of testosterone boosting drugs. Report | Follow @EricPFierce
@CarlyHFierce: More Humira sales gains help AbbVie meet forecasts. News | Follow @CarlyHFierce
> WSJ: Scientist's lawsuit accuses AstraZeneca of fudging Brilinta study. More
> Suitors size up Merck's consumer unit for potential $10B deal: Reuters. Story
> Valeant adds to skin-care quiver with $475M PreCision Dermatology buy. News
CRO News
> Parexel rebounds from a shaky fall as sales jump 15%. Article
> Indian CRO GVK buys its way into biologics with Aragen deal. Story
> Ergomed cuts a risk-sharing deal on Ferrer's insomnia drug. News
> InVentiv looks to corner the market on mid-size biotechs. Story
> Growing Novotech makes its way into Africa. Article
> Algorithme doubles down on complex trials with latest addition. Brief
Biotech IT News
> J&J hands Yale the keys to its clinical trial data vault. Story
> Dassault makes a $750M play for Accelrys to expand into R&D software. Article
> Infosys co-founder backs an Indian brain computing center. News
> Bioinformatics skills help Stanford to a $40M genomics grant. Story
> The FDA's Mini-Sentinel healthcare surveillance database is growing quickly. Article
> Empiriko teams up to scale liver-mimicking technology. Brief